Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abiomed Inc (ABMD)

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,715,105
  • Shares Outstanding, K 45,377
  • Annual Sales, $ 769,430 K
  • Annual Income, $ 259,020 K
  • 60-Month Beta 0.31
  • Price/Sales 11.33
  • Price/Cash Flow 48.04
  • Price/Book 8.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.93
  • Number of Estimates 6
  • High Estimate 1.01
  • Low Estimate 0.86
  • Prior Year 0.81
  • Growth Rate Est. (year over year) +14.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.02 +6.62%
on 08/08/19
285.77 -32.46%
on 07/31/19
-60.74 (-23.94%)
since 07/16/19
3-Month
181.02 +6.62%
on 08/08/19
285.77 -32.46%
on 07/31/19
-69.13 (-26.37%)
since 05/16/19
52-Week
181.02 +6.62%
on 08/08/19
459.75 -58.02%
on 10/01/18
-175.96 (-47.69%)
since 08/16/18

Most Recent Stories

More News
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Abiomed, Inc. Investors of Important Deadline in Securities Class Action - ABMD

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abiomed, Inc. (NASDAQ: ABMD) from January 31, 2019 through July 31, 2019, inclusive (the "Class Period") of the...

ABMD : 193.01 (+0.49%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ABIOMED, Inc. of Class Action Lawsuit and Upcoming Deadline - ABMD

Pomerantz LLP announces that a class action lawsuit has been filed against ABIOMED, Inc. ("ABIOMED" or the "Company") (NASDAQ: ABMD) and certain of its officers. The class action, filed in United States...

ABMD : 193.01 (+0.49%)
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Abiomed, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming October 7, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Abiomed, Inc. ("Abiomed" or the "Company")...

ABMD : 193.01 (+0.49%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In ABIOMED, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ABIOMED, Inc. ("ABIOMED" or the "Company")(NASDAQ:ABMD) of the October 7, 2019 deadline to seek the role of lead plaintiff...

ABMD : 193.01 (+0.49%)
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Abiomed, Inc.

Law Offices of Howard G. Smith reminds investors of the upcoming October 7, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Abiomed, Inc. ("Abiomed"...

ABMD : 193.01 (+0.49%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FRED, CARB, ABMD and IFF

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

CARB : 14.48 (-4.86%)
ABMD : 193.01 (+0.49%)
IFF : 112.78 (+1.96%)
FRED : 0.31 (unch)
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Abiomed, Inc. ("Abiomed" or "the Company") (NASDAQ: ABMD) for violations of §§10(b)...

ABMD : 193.01 (+0.49%)
Relatively Good Performance Detected in Shares of Dexcom in the Health Care Equipment Industry (DXCM , BAX , ABMD , TNDM, WMGI )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

TNDM : 58.76 (+2.89%)
ABMD : 193.01 (+0.49%)
BAX : 86.97 (+1.39%)
DXCM : 163.68 (+3.25%)
CLASS ACTION UPDATE for FDX, FRED, EGBN and ABMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...

ABMD : 193.01 (+0.49%)
FRED : 0.31 (unch)
FDX : 156.00 (+2.08%)
EGBN : 39.93 (+3.20%)
Nevro Corp is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (NVRO , ABMD , ZBH , INGN , HRC )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

NVRO : 80.76 (-0.04%)
ZBH : 137.01 (+1.39%)
ABMD : 193.01 (+0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ABMD with:

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

2nd Resistance Point 195.74
1st Resistance Point 194.38
Last Price 193.01
1st Support Level 191.74
2nd Support Level 190.47

See More

52-Week High 459.75
Fibonacci 61.8% 353.28
Fibonacci 50% 320.39
Fibonacci 38.2% 287.49
Last Price 193.01
52-Week Low 181.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar